| Date Checked | 2026-02-19 22:13:34 |
|---|---|
| Graham Number | (PB)49.52 vs (PE)49.93 |
| Over / Under Value Percentage | 144.64% vs 143.81% |
| Dividend Yield | 2.20% |
| Dividend Date | 2026-02-13 |
| Symbol | ABT |
| AssetType | Common Stock |
| Name | Abbott Laboratories |
| Description | Abbott Laboratories (ABT) is a leading American multinational healthcare company headquartered in Abbott Park, Illinois, renowned for its broad expertise in medical devices, diagnostics, nutritional products, and branded generic medicines. Founded in 1888, Abbott has consistently prioritized innovation, leveraging advanced technology to improve health outcomes and provide comprehensive healthcare solutions worldwide. The company's strategic spin-off of its pharmaceutical division into AbbVie in 2013 has allowed it to sharpen its focus on its core sectors while sustaining a strong legacy of quality and excellence. With a significant global footprint, Abbott is well-equipped to seize emerging market opportunities and adapt to the changing landscape of healthcare needs. |
| CIK | 1800 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL DEVICES |
| Address | 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, UNITED STATES, 60064-6400 |
| OfficialSite | https://www.abbott.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-12-31 |
| MarketCapitalization | 192895074000 |
| EBITDA | 11492666000 |
| PERatio | 29.79 |
| PEGRatio | 4.168 |
| BookValue | 29.3 |
| DividendPerShare | 2.4 |
| EPS | 3.72 |
| RevenuePerShareTTM | 25.34 |
| ProfitMargin | 0.147 |
| OperatingMarginTTM | 0.22 |
| ReturnOnAssetsTTM | 0.0679 |
| ReturnOnEquityTTM | 0.132 |
| RevenueTTM | 44328002000 |
| GrossProfitTTM | 25140001000 |
| DilutedEPSTTM | 3.72 |
| QuarterlyEarningsGrowthYOY | -0.808 |
| QuarterlyRevenueGrowthYOY | 0.044 |
| AnalystTargetPrice | 133.11 |
| AnalystRatingStrongBuy | 6 |
| AnalystRatingBuy | 15 |
| AnalystRatingHold | 7 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 29.79 |
| ForwardPE | 19.53 |
| PriceToSalesRatioTTM | 4.351 |
| PriceToBookRatio | 3.782 |
| EVToRevenue | 4.465 |
| EVToEBITDA | 19.15 |
| Beta | 0.751 |
| 52WeekHigh | 138.63 |
| 52WeekLow | 105.27 |
| 50DayMovingAverage | 121.15 |
| 200DayMovingAverage | 128.63 |
| SharesOutstanding | 1738872000 |
| SharesFloat | 1728560000 |
| PercentInsiders | 0.541 |
| PercentInstitutions | 81.709 |
| ExDividendDate | 2026-01-15 |
| etoro | 1 |
| dateChecked | 2026-02-19 22:13:34 |
| fresh | 1 |